OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11053	Companies
242366	Keywords
170662	Articles
130456	Press releases

Home
Companies
OXURION

BRIEF

published on 05/12/2025 at 18:05, 1 year 4 months ago

Oxurion annonce des franchissements de seuils d'actions par Atlas Special Opportunities

Notification De Transparence Oxurion Opportunités Spéciales Atlas Seuils De Participation Thérapies Contre Les Maladies Rétiniennes
PRESS RELEASE

published on 05/12/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease

Biopharmaceutical Shareholding Changes Ophthalmic Therapies Oxurion NV Transparency Notifications
PRESS RELEASE

published on 05/12/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelentransacties en voldoet aan Belgische transparantiewetgeving. Het biofarmaceutisch bedrijf ontwikkelt oftalmologische therapieën

Transparantiekennisgevingen Oxurion NV Oftalmologische Therapieën Belgische Transparantiewetgeving Biofarmaceutisch Bedrijf
BRIEF

published on 05/09/2025 at 18:05, 1 year 4 months ago

Oxurion Increases Capital Following Convertible Bond Conversion

Convertible Bonds Capital Increase Atlas Special Opportunities Vision Preservation Oxurion Shares
BRIEF

published on 05/09/2025 at 18:05, 1 year 4 months ago

Oxurion augmente son capital suite à la conversion d'obligations convertibles

Obligations Convertibles Augmentation De Capital Opportunités Spéciales Atlas Préservation De La Vision Actions Oxurion
PRESS RELEASE

published on 05/09/2025 at 18:00, 1 year 4 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, resulting in EUR 100,000 capital increase, supporting innovative therapeutics development for vision preservation in elderly. Oxurion shares update post-capital increase

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Vision Preservation
PRESS RELEASE

published on 05/09/2025 at 18:00, 1 year 4 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC converteert 4 obligaties in Oxurion, resulterend in EUR 100.000 kapitaalverhoging. Oxurion verstrekt 1.521.372 gewone aandelen. Meer info op www.oxurion.com

Kapitaalverhoging Atlas Special Opportunities Aandelen Oxurion Innovatieve Geneesmiddelen
BRIEF

published on 04/25/2025 at 18:35, 1 year 4 months ago

Oxurion Arrête une Transaction de 2024 et Continue les Négociations pour une Nouvelle Acquisition

Acquisition Négociations CRO Oxurion Biométrie
BRIEF

published on 04/25/2025 at 18:35, 1 year 4 months ago

Oxurion Stops 2024 Transaction and Continues Negotiations for New Acquisition

Acquisition Negotiations CRO Oxurion Biometrics
PRESS RELEASE

published on 04/25/2025 at 18:30, 1 year 4 months ago

Oxurion kondigt stopzetting aan van de transactie van juli 2024 en bevestigt de voortzetting van de gesprekken over het overnameproject aangekondigd in maart 2025
Oxurion NV (Euronext Brussels: OXUR) stops negotiations for majority stake acquisition in French CRO, continues talks for majority stake in CRO specializing in biometrics and advanced data management. Market updates to follow

Majority Stake Acquisition Clinical Studies CRO Oxurion NV Biometrics

Accesswire

Published on 09/22/2026 at 22:01, 19 minutes ago

Fermi and TensorWave Agree to Extend Closing Date to October 31, 2026
Published on 09/22/2026 at 21:40, 40 minutes ago

Sekur Private Data Launches Sekur.com in Portuguese in Preparation for Angola Launch
Published on 09/22/2026 at 17:00, 5 hours 20 minutes ago

Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 16:30, 5 hours 50 minutes ago

Formation Metals Intersects 0.98 g/t Au over 95.6 Metres Starting 7 Metres Below Surface, Including 3.14 g/t Au over the First 10 Metres, Extending the A-Zone Up to 50 Metres North at N2
Published on 09/22/2026 at 15:25, 6 hours 55 minutes ago

Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 19:40, 2 hours 39 minutes ago

EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 3 hours 20 minutes ago

LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:45, 3 hours 34 minutes ago

MGI Digital Technology: Modification des ressources allouées au contrat de liquidité.
Published on 09/22/2026 at 18:30, 3 hours 49 minutes ago

Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 18:30, 3 hours 50 minutes ago

Voyageurs du Monde: Communiqué sur le dépôt de projet de note en réponse (suite au dépôt de projet de note en réponse de Voyageurs du Monde à l'Autorité des Marchés Financiers)

Les Echos

Published on 09/22/2026 at 18:10, 4 hours 10 minutes ago

Financial statements - 30 june 2026
Published on 09/22/2026 at 18:00, 4 hours 20 minutes ago

Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 4 hours 20 minutes ago

Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 4 hours 35 minutes ago

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/22/2026 at 17:45, 4 hours 35 minutes ago

Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026

View all LES ECHOS COMFI WIRE